VEGFA and glioblastoma: This result corroborates the in silico analysis and supports the hypothesis that iHDAC mainly targets the components of the U87MG GBM cell secretome involved in angiogenesis and angiogenesis-related biological process, the AngioMatrix, in a FN and VEGF independent fashion.